- Research Article
- 10.1016/j.adcanc.2025.100166
Repurposing statins in combination therapy for effective ablation of metastatic breast cancer
- Jul 01, 2026
- Advances in Cancer Biology - Metastasis
- Rifat Aara + 11 more +11
Publications from 2021 to 2026
Showing 10 of 919 papers
Repurposing statins in combination therapy for effective ablation of metastatic breast cancer
Spatial transcriptomic analysis of the immune landscape following <scp>NBUVB</scp> treatment of vitiligo skin
Abstract Objectives Vitiligo is an autoimmune disorder characterised by the presence of depigmented lesions on the skin. The autoreactive cytotoxic T cells at the epidermal‐dermal junction of the skin facilitate the targeted destruction of epidermal melanocytes, leading to the development of vitiligo lesions. Narrow‐band UVB (NBUVB) phototherapy is a widely used non‐invasive treatment that promotes transient repigmentation of lesions. However, the specific effects of NBUVB on skin dermal T cells in vitiligo patients remain largely unexplored. Insights into the mechanism of action of NBUVB phototherapy can guide therapies against cytotoxic T cells, enabling effective and sustained remission of vitiligo lesions. Methods Indian patients with active vitiligo lesions underwent 3 months of NBUVB phototherapy, thereby leading to successful repigmentation of vitiligo lesions. Spatial transcriptomic and histological analyses were employed to investigate the gene expression profiles of dermal T cells at the epidermal‐dermal junction, both before and after treatment. Results Comprehensive spatial transcriptome analysis of skin dermal T cells revealed that NBUVB phototherapy leads to the overall suppression of inflammatory genes and immune regulatory pathways that are upregulated in vitiligo patients before treatment. Consequently, tissue‐resident innate and adaptive immune cells significantly decrease post‐UVB phototherapy. Interestingly, we observe an increase in naïve CD4 + T cells post‐UVB phototherapy. Conclusion NBUVB phototherapy effectively suppresses the innate and adaptive immune cell populations and immune regulatory pathways while promoting an increase in naïve CD4 + T cells. These findings underscore a previously unrecognised immunomodulatory role of NBUVB phototherapy in vitiligo patients.
Read moreThe low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virus
Hepatitis A virus (HAV) is an unusual picornavirus with two types of extracellular virions: nonenveloped particles (nHAV) shed in feces and quasi-enveloped particles (eHAV) circulating in blood. Both enter cells by clathrin-dependent endocytic pathways merging in late endolysosomes with capsid binding to ganglioside receptors. Phosphatidylserine receptors facilitate eHAV endocytosis, but no protein receptor has been identified for nHAV. Here, we show low-density lipoprotein receptor (LDLR) is such a receptor. LDLR knockout did not alter viral attachment to cells, but restricted cellular uptake of nHAV (not eHAV). Soluble LDLR ectodomain blocked nHAV entry, as did antibody to LDLR. Recombinant LDLR-related protein-associated protein 1, a pan-LDLR family chaperone, also inhibited nHAV entry, including residual entry into knockout cells, suggesting other LDLR family members may similarly facilitate endocytosis. Reconstituting full-length LDLR expression restored nHAV entry in knockout cells, whereas LDLR mutants lacking LA repeats 4 to 7 or the EGF-like/propeller domain did not. ELISAs confirmed LDLR binds nHAV, optimally above pH7, without destabilizing the capsid. A 1.7Å resolution cryoelectron microscopy (cryo-EM) structure revealed LDLR interacts with VP1 at the fivefold vertex of the capsid. Extreme blurring of the LDLR density prevented detailed identification of LDLR interactions, and suggested binding does not follow particle symmetry, being either flexible or to multiple LDLR regions. Additional cryo-EM studies show ganglioside GD1a binds to a similar region of the capsid. Collectively, these data reveal the LDLR to be an important entry factor, shuttling nHAV from the extracellular environment to endolysosomes where it is likely released at low pH to bind gangliosides.
Read moreDopamine release from Parkinson’s patient-derived neurons is disrupted due to impaired synaptic vesicle loading
Abstract Striatal dopamine release defects are an early pathological feature observed in diverse models of Parkinson’s disease. However, the underlying molecular mechanisms responsible, and potential links to disease aetiology in humans, have been elusive. Here, we tested the hypothesis that dopamine release deficits are a characteristic feature of disease-relevant human neurons, using human Parkinson’s patient iPSC-derived dopamine neurons carrying the SNCA -triplication mutation. We reveal deficits in dopamine release from SNCA -triplication patient-derived neurons, and identify that this is due to reduced dopamine content arising from a lower capacity to store dopamine through reduced expression and function of vesicular monoamine transporter 2 (VMAT2) compared to healthy controls. In turn, by imaging VMAT substrate FFN206, and reporters for synaptic vesicular dynamics, SynaptopHluorin and CypHer5E, we reveal corresponding deficits in the size of either VMAT-containing, presynaptic releasing or recycling vesicle pools. Consistent with diminished synaptic vesicle loading and recycling, the cytosolic turnover of dopamine indicated by the ratio of concentrations of dopamine metabolite DOPAC to dopamine was elevated. By contrast, glutamate release events and VGLUT2 levels in neurons in the same preparations were not disturbed, demonstrating that vesicular dysfunction is limited to vesicles for dopamine. These findings therefore reveal dopamine loading into vesicles as a locus of dysfunction in human Parkinson’s-derived neurons. These disturbances will not only drive deficits in dopamine release but could potentially also be detrimental to dopamine neuron viability through an increased burden of oxidative stress associated with elevated cytosolic dopamine, thus contributing to both symptoms and aetiology of Parkinson’s pathology and offering a strategic target for improved therapies.
Read moreSpike Antibody Fc Drives Protection from SARS-CoV-2 Challenge in Macaques
Abstract A definitive correlate of protection (CoP) for SARS-CoV-2 has yet to be formally established. Previously, using data from a series of non-human primate vaccine challenge studies, we reported that neutralising antibodies (NAbs) are the strongest candidate for clinical protection against COVID-19 and that spike binding antibody is the strongest candidate CoP for viral burden post-challenge. In this study, we further characterised the protective binding antibody profile by analysing spike antibody-dependent complement deposition, FcγR binding, isotype and antibody glycosylation. Using the machine learning platform SIMON, we demonstrate that antibody-dependent complement deposition (ADCD) and FcγR binding are strong candidate co-correlates for each of the post-challenge outcomes; viral load and lung pathology. We found that spike antibody sialylation closely followed by FcγR2A, was the spike antibody feature with the strongest negative correlation with histopathology score. Spike antibody ADCD, FcγR binding, isotype and glycosylation significantly differed by immunisation regimen and sex, which demonstrates the heterogeneity of immune mechanisms induced by different immunisation platforms. We conclude that spike binding antibody, with the protective functional characteristics described herein, is a candidate CoP that captures both protection from severe clinical disease and protection against a high viral burden. These findings should be taken into consideration for future SARS-CoV-2 vaccine development.
Read moreThe epidemiology of cubital tunnel syndrome: a UK Biobank case-control study.
Cubital tunnel syndrome is the second most prevalent upper limb compression neuropathy. Limitations in non-operative and surgical treatment warrant an adjunctive preventative approach targeting modifiable risk factors. However, risk factors are poorly characterized given methodologic shortcomings in previous studies. In this case-control study in the UK Biobank (1971 cases, 398,639 controls), multivariable logistic regression with extensive covariate correction was conducted to assess the association between cubital tunnel syndrome and sex, age, ethnicity, socioeconomic deprivation, smoking status, alcohol intake, height, body mass index, plasma lipids, HbA1c, diabetes, hypertension, carpal tunnel syndrome, osteoarthritis, rheumatoid arthritis, hypothyroidism and gastroesophageal reflux disease. Cubital tunnel syndrome was significantly associated with several modifiable risk factors: smoking status (odds ratio 2.08, 95% CI: 1.83-2.37), diabetes with microvascular complications (OR 1.80, 95% CI: 1.40-2.30), hypertension (OR 1.37, 95% CI: 1.24-1.52) and raised body mass index (OR 1.13, 95% CI: 1.08-1.19). Male sex (OR 1.77, 95% CI: 1.54-2.04) and age (OR 0.981, 95% CI: 0.975-0.986) were non-modifiable risk factors. Several comorbidities were associated with cubital tunnel syndrome: carpal tunnel syndrome (OR 11.7, 95% CI: 10.6-12.9), osteoarthritis (OR 2.12, 95% CI: 1.92-2.34), rheumatoid arthritis (OR 1.72, 95% CI: 1.42-2.07), and gastroesophageal reflux disease (OR 1.66, 95% CI: 1.50-1.83). Cubital tunnel syndrome had a weak association with socioeconomic deprivation and no association with ethnicity, height, alcohol intake, plasma lipids, HbA1c and hypothyroidism. Cubital tunnel syndrome is robustly associated with several modifiable risk factors that may be targeted in primary and secondary prevention. III.
Read moreBerberine alleviates radiation-induced lung injury by promoting microbiota-derived inosine via the gut–lung axis
Identification of a novel hypomorphic variant in CYBB underlying an adult presentation of X-linked recessive Mendelian susceptibility to mycobacterial disease.
Deleterious mutations in the CYBB gene encoding NOX2 typically cause X-linked recessive chronic granulomatous disease (XR-CGD) by affecting NADPH oxidase-dependent respiratory burst in phagocytes. However, two missense variants (T178P, Q231P) were previously shown to cause isolated Mendelian susceptibility to mycobacterial disease (MSMD) in otherwise healthy males. We describe a novel, private variant in CYBB (c.998C > A, p.S333Y) identified in a male patient with adult-onset disseminated Mycobacterium avium infection. Despite preserved transcript levels, NOX2 protein expression was reduced in the patient's cells. Functionally, an intermediate phenotype was observed, characterized by reduced but not abolished ROS production, with a cell-type specific degree of impairment. This case represents the second report of isolated X-linked recessive MSMD caused by a missense CYBB variant, and the first case presenting in adulthood. Our findings indicate a hypomorphic variant that impairs respiratory burst in a cell type-specific manner, extending previous observations in two kindreds with CYBB-associated MSMD.
Read moreContext-specific regulatory genetic variation in MTOR dampens neutrophil-T cell crosstalk in pneumonia-associated sepsis.
Sepsis is a heterogeneous clinical syndrome with a high mortality, requiring personalised stratification strategies. Here, we characterise genetic variation that modulates MTOR, a critical regulator of metabolism and immune responses in sepsis. The effects are context specific, involving a regulatory element that affects MTOR expression in activated T cells with opposite effect in neutrophils. We show that the G-allele of the lead variant, rs4845987, which is associated with decreased risk of type 2 diabetes, reduces MTOR expression in T cells and improves survival in sepsis due to pneumonia, with effects specific to sepsis endotype. Using ex vivo models, we demonstrate that activated T cells promote immunosuppressive neutrophils through released cytokines, a process dampened by hypoxia and the mTOR inhibitor rapamycin. Our work demonstrates an epigenetic mechanism fine-tuning MTOR transcription and T cell activity via the variant-containing regulatory element, which further exhibits an allelic effect upon vitamin C treatment. These findings reveal how genetic variation interacts with disease state to modulate immune cell-cell communication, providing a framework for stratified therapy in sepsis.
Read moreBuilding scalable neuroimaging programs across diverse human environments.